Cochlear Implantation in Meniere's Disease: A Systematic Review and Meta-Analysis
- PMID: 33464598
- DOI: 10.1002/lary.29393
Cochlear Implantation in Meniere's Disease: A Systematic Review and Meta-Analysis
Abstract
Objectives/hypothesis: Meniere's disease (MD) is a debilitating condition characterized by hearing loss, vertigo, and tinnitus. The objective of this study was to systematically investigate outcomes in MD after cochlear implantation (CoI), with and without labyrinthectomy.
Study design: Systematic review and meta-analysis.
Methods: A systematic review of articles in Medline and Embase was performed to identify all studies of patients with MD who underwent CoI. This analysis evaluates outcomes of speech recognition, pure tone audiometry, vertigo, tinnitus, and quality of life.
Results: Of 321 studies identified, 37 were included, involving 216 patients. Mean age at implantation was 61.4 years (range 27-85 years) with average length of follow-up at 1.7 years (range 0-9 years). Forty-four (20.4%) patients underwent labyrinthectomy. Meta-analysis demonstrated significant improvements in audiometric outcomes following CoI. There was a statistically significant improvement in Hearing in Noise Test performance, with a mean difference improvement of 44.7 (95% confidence interval [CI] [8.8, 80.6]) at 6 months and 60.1 (95% CI [35.3, 85.0]) at 12 months. The Freiburger Monosyllabic Test (FMT) and Consonant-Nucleus-Consonant (CNC) also improved significantly, with mean difference improvements of 46.2 (95% CI [30.0, 62.4]) for FMT and 19.3 (95% CI [8.1, 30.4]) for CNC. There was a statistically significant decrease in tinnitus, as measured by a mean difference reduction of 48.1 (95% CI [1.0, 95.2]) in the Tinnitus Handicap Index.
Conclusions: CoI with and without simultaneous labyrinthectomy is a viable treatment option for patients with MD, yielding high rates of tinnitus suppression and vertigo control. Post-CoI MD patients demonstrate similar postoperative speech perception outcomes to non-MD implant recipients. Laryngoscope, 131:1845-1854, 2021.
Keywords: Meniere's disease; cochlear implant; deafness; dizziness; endolymphatic hydrops; hearing loss; speech recognition; tinnitus; vertigo.
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Long-term outcome of patients with Ménière's disease following cochlear implantation: a comprehensive outcome study with validated assessment tools.Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4689-4701. doi: 10.1007/s00405-024-08690-1. Epub 2024 May 20. Eur Arch Otorhinolaryngol. 2024. PMID: 38767697 Free PMC article.
-
Cochlear implantation in patients with bilateral Ménière's syndrome.Otol Neurotol. 2003 May;24(3):397-403. doi: 10.1097/00129492-200305000-00009. Otol Neurotol. 2003. PMID: 12806291
-
[Simultaneous triple semicircular canal plugging and cochlear implantation in advanced Meniere's disease].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jan 7;52(1):25-30. doi: 10.3760/cma.j.issn.1673-0860.2017.01.005. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28104012 Chinese.
-
Surgical Management of Intractable Meniere's Disease.Int Tinnitus J. 2022 Jun 21;26(1):50-56. doi: 10.5935/0946-5448.20220007. Int Tinnitus J. 2022. PMID: 35861458 Review.
-
Cochlear implantation in Ménière's disease: a systematic review of literature and pooled analysis.Int J Audiol. 2020 Jun;59(6):406-415. doi: 10.1080/14992027.2020.1720922. Epub 2020 Feb 6. Int J Audiol. 2020. PMID: 32027195
Cited by
-
Deafness Progressing to Cochlear Implant Eligibility Is Eight Times More Likely in the Hypoplastic Than the Degenerative Endotype of Menière's Disease.Otol Neurotol. 2025 Jun 1;46(5):e170-e175. doi: 10.1097/MAO.0000000000004482. Epub 2025 Mar 20. Otol Neurotol. 2025. PMID: 40164978 Free PMC article.
-
Long-term outcome of patients with Ménière's disease following cochlear implantation: a comprehensive outcome study with validated assessment tools.Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4689-4701. doi: 10.1007/s00405-024-08690-1. Epub 2024 May 20. Eur Arch Otorhinolaryngol. 2024. PMID: 38767697 Free PMC article.
-
The Chronological Evolution of Cochlear Implant Contraindications: A Comprehensive Review.J Clin Med. 2024 Apr 18;13(8):2337. doi: 10.3390/jcm13082337. J Clin Med. 2024. PMID: 38673610 Free PMC article. Review.
-
Role of prior intratympanic gentamicin and corticosteroids therapy on speech understanding in patients with Menière's disease after cochlear implantation.Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3483-3490. doi: 10.1007/s00405-024-08449-8. Epub 2024 Feb 2. Eur Arch Otorhinolaryngol. 2024. PMID: 38302621 Free PMC article.
-
Significance of endolymphatic sac surgery with and/or without simultaneous cochlea implant surgery in respect of vertigo control and speech perception in patients with Menière's disease.Eur Arch Otorhinolaryngol. 2024 Feb;281(2):639-647. doi: 10.1007/s00405-023-08122-6. Epub 2023 Jul 20. Eur Arch Otorhinolaryngol. 2024. PMID: 37470816 Free PMC article.
References
BIBLIOGRAPHY
-
- Minor LB, Schessel DA, Carey JP. Meniere's disease. Curr Opin Neurol 2004;17:9-16.
-
- Huppert D, Strupp M, Bradt T. Long-term course of Meniere's disease revisited. Acta Otolaryngol 2010;130:644-651.
-
- Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: Meniere's disease. J Otolaryngol Head Neck Surg 2020;162:S1-S55.
-
- Wareing M, O'Connor AF. The role of labyrinthectomy and cochlear implantation. Ear Nose Throat J 1997;76:664-669.
-
- Hansen M, Gantz B, Dunn C. Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Meniere's disease. Otol Neurotol 2013;34:1681-1687.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical